Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding

NCT07169214 is registered in ClinicalTrials.gov with ScinnoHub Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT07169214
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07169214 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding
Lead sponsor
ScinnoHub Pharmaceutical Co., Ltd.
Phase
Phase 1
Overall status
Recruiting
Start date
October 30, 2024
Completion date
December 31, 2025
Enrollment
39 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

abnormal uterine bleeding